Citius (CTOR) enters distribution agreement with Cardinal Health (CAH)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
June 9, 2025 8:37 AM EDTAgreement supports the upcoming launch of LYMPHIR for the treatment of cutaneous T-cell lymphoma
CRANFORD, N.J., June 9, 2025 /PRNewswire/ --Â Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class... More
